Maternal immunization against viral disease (Q77122444)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9711788%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

review article

1 reference

title

Maternal immunization against viral disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9711788%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J Englund

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9711788%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

W P Glezen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9711788%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

P A Piedra

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9711788%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

language of work or name

English

0 references

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9711788%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9711788%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9711788%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

14-15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9711788%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

1456-1463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9711788%20AND%20SRC:MED&resulttype=core&format=json

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Protection of infants from infection with influenza A virus by transplacentally acquired antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

In utero vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Transplacental immunization of the human fetus to tetanus by immunization of the mother

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Oral polio vaccination during pregnancy: no increase in the occurrence of congenital malformations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Congenital anomalies after oral poliovirus vaccination during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Effect of maternal immunization with oral poliovirus vaccine on neonatal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Congenital yellow fever virus infection after immunization in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Respiratory syncytial virus-specific immunoglobulins in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Immunization to prevent group B streptococcal disease: victories and vexations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Poliomyelitis in pregnancy: effect on fetus and newborn infant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Response of pregnant women and their infants to poliomyelitis vaccine; distribution of poliovirus antibody in pregnant women before and after vaccination; transfer, persistence, and induction of antibodies in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Oral polio vaccination during pregnancy: lack of impact on fetal development and perinatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Observations on excess mortality associated with epidemic influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

A prospective study of influenza infections during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Immunization of Pregnant Women with Influenza A/New Jersey/76 Virus Vaccine: Reactogenicity and Immunogenicity in Mother and Infant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Acute respiratory infections in children: etiology and epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Community- and hospital-acquired respiratory syncytial virus infections in Chile.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Respiratory syncytial virus and acute lower respiratory infections in Benin City, Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Etiology of acute lower respiratory tract infections in children in a rural community in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Epidemiology of acute respiratory infections in young children from Thailand.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Neonatal respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Respiratory syncytial viral infection in infants with congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Respiratory syncytial viral infection in children with compromised immune function

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Passive protection against respiratory syncytial virus disease in infants: the role of maternal antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Immunity to and frequency of reinfection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Variation in severity of respiratory syncytial virus infections with subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Respiratory syncytial virus in early infancy. Circulating antibody and the severity of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Maternal antibody and respiratory syncytial virus infection in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Antibodies to respiratory syncytial virus polypeptides and their significance in human infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Immunogenicity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

The guinea pig as a model for the study of maternal immunization against respiratory syncytial virus infections in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Vaccination of pregnant macaques protects newborns against mucosal simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900108-X

7 January 2021

10.1016/S0264-410X(98)00108-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9711788%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9711788%20AND%20SRC:MED&resulttype=core&format=json